LABRYS BIOLOGICS
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.
LABRYS BIOLOGICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
45.59 M USD
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
KBP Biosciences
A multinational clinical stage biotechnology company.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Labrys Biologics
Sofinnova Investments
Sofinnova Investments investment in Series A - Labrys Biologics
venBio Partners
venBio Partners investment in Series A - Labrys Biologics
InterWest Partners
InterWest Partners investment in Series A - Labrys Biologics
InterWest Partners
InterWest Partners investment in Venture Round - Labrys Biologics
Canaan Partners
Canaan Partners investment in Venture Round - Labrys Biologics
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Labrys Biologics